Coronary Artery Disease
Coronary Artery Disease (CAD) is a condition where the blood vessels supplying blood to the heart become narrowed or blocked, often leading to chest pain or heart attacks.
Coronary Artery Disease: Comparing Diabetes Medications
We are studying how well a new diabetes medication works to improve heart health in people with coronary artery disease and prediabetes. This trial compares a GLP-1 agonist and an SGLT-2 inhibitor to standard treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Prediabetes
Prediabetes is a health condition where blood sugar levels are higher than normal but not yet high enough to be diagnosed as diabetes, increasing the risk of developing type 2 diabetes.
Coronary Atherosclerosis
Coronary Atherosclerosis is a condition characterized by the buildup of plaque in the coronary arteries, which can restrict blood flow to the heart and lead to serious complications.
Coronary Heart Disease
Coronary Heart Disease (CHD) occurs when the coronary arteries become narrowed or blocked, leading to reduced blood flow to the heart muscle, which can cause chest pain and other serious heart issues.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 80 years old?
- Do you have coronary artery disease (narrowing of the heart arteries)?
- Are you currently pregnant or breastfeeding?
- Are you taking any diabetes medications other than metformin, like insulin or glipizide?
- Do you have diabetes (with an HbA1c greater than 6.5%)?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Abmetfina Xr
Adimet
Adimet Xr
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy
Klinika Choroby Wieńcowej i Strukturalnych Chorób Serca, Oddział kliniczny
Wawer, Poland
Sponsor: Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.